Phio Pharmaceuticals
| Region | Nordamerika |
| ISIN | US71880W2044 |
| Sektor | Biotechnologie |
| Website | http://www.phiopharma.com |
Phio Pharmaceuticals is focused on developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYLTM) therapeutic platform. Immunotherapies harness our immune system to restore surveillance of tumors that evade detection – a potential curative medicine. INTASYLTM therapeutics can be used as a standalone treatment or in combination with other modalities.
| Titel | Autor | Datum |
|---|---|---|
|
In Wahrheit 100 Mal so viel wert?
|
sharedeals | translation missing: de.datetime.time_ago_in_words.almost_x_years |
| Titel | Datum |
|---|---|
| Insider Moves: Eduspec Holdings Bhd, CB Industrial Product Holding Bhd, MISC Bhd, Oasis Harvest Corp Bhd | vor ungefähr 2 Monaten |
| Bumi Armada, MISC, Zetrix, Heitech Padu, Kelington, Kim Hin, Hibiscus, Johor Plantations Group, Ajiya, Pekat, Kimlun, Jiankun & Farm Price | vor ungefähr 2 Monaten |
| MISC, Bumi Armada call off merger proposal | vor ungefähr 2 Monaten |
| DNV awards GASA approval to joint LCO2 carrier design by MOL, MISC, PETRONAS CCS Ventures and SDARI | vor ungefähr 3 Monaten |
| MOL, MISC and PETRONAS form joint venture to advance cross-border CO2 transportation | vor ungefähr 4 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| PayPal (1 Artikel) | |
| Palatin Technologies (4 Artikel) | |
| Premier Gold Mines (1 Artikel) | |
| QIAGEN (1 Artikel) | |
| Alle anzeigen | |